Spruce Biosciences, Inc. (SPRB) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$52.47
Day's range
$64.61

Spruce Biosciences Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
IKARIAN CAPITAL, LLC 05/15/2026 121.36 K $7.93 M   0.00% 15.83%
MILLENNIUM MANAGEMENT LLC 05/15/2026 111.89 K $7.31 M   100.00% 14.60%
CITADEL ADVISORS LLC 05/15/2026 70.00 K $4.57 M   0.00% 9.13%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 58.60 K $3.83 M   1.03% 7.64%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 51.67 K $3.38 M   0.00% 6.74%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 48.80 K $3.19 M   -17.22% 6.37%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 42.08 K $2.75 M   -12.21% 5.49%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 40.00 K $2.61 M   0.00% 5.22%
CARLYLE GROUP INC. 05/08/2026 38.62 K $2.52 M   0.00% 5.04%
QUINN OPPORTUNITY PARTNERS LLC 05/15/2026 26.81 K $1.75 M   17.54% 3.50%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2026 22.00 K $1.44 M   -12.94% 2.87%
05/15/2026 18.34 K $1.20 M   100.00% 2.39%
BLACKROCK, INC. 05/13/2026 16.94 K $1.11 M   0.00% 2.21%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 12.89 K $842.73 K   1.23% 1.68%
05/15/2026 12.20 K $797.27 K   -82.57% 1.59%
DIADEMA PARTNERS LP 05/15/2026 10.00 K $653.50 K   100.00% 1.30%
STEMPOINT CAPITAL LP 05/18/2026 6.36 K $415.63 K   100.00% 0.83%
VANGUARD FIDUCIARY TRUST CO 05/15/2026 5.51 K $360.34 K   100.00% 0.72%
GOLDMAN SACHS GROUP INC 05/15/2026 5.51 K $359.82 K   100.00% 0.72%
STATE STREET CORP 05/15/2026 5.40 K $352.89 K   -15.63% 0.70%
RESOLUTE CAPITAL ASSET PARTNERS LLC 05/15/2026 4.00 K $261.40 K   0.00% 0.52%
UBS GROUP AG 05/05/2026 3.92 K $256.11 K   -20.05% 0.51%
PERSISTENT ASSET PARTNERS LTD 05/12/2026 2.53 K $165.21 K   100.00% 0.33%
MORGAN STANLEY 05/15/2026 1.42 K $92.47 K   264.69% 0.18%
LION POINT CAPITAL, LP 05/15/2026 1.00 K $65.35 K   0.00% 0.13%
CITIGROUP INC 05/11/2026 939 $61.36 K   100.00% 0.12%
VANGUARD GLOBAL ADVISERS, LLC 05/15/2026 452 $29.54 K   100.00% 0.06%
SOUND INCOME STRATEGIES, LLC 04/27/2026 200 $13.91 K   0.00% 0.03%
JONES FINANCIAL COMPANIES LLLP 05/15/2026 193 $12.17 K   129.76% 0.03%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 140 $9.15 K   13,900.00% 0.02%
CALDWELL SUTTER CAPITAL, INC. 05/06/2026 13 $850   0.00% 0.00%
CASSADAY & CO WEALTH MANAGEMENT LLC 05/07/2026 2 $130   100.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/18/2026 0 $0   -100.00% 0.00%
NORTHERN TRUST CORP 05/14/2026 0 $0   -100.00% 0.00%
ROYAL BANK OF CANADA 05/15/2026 0 $0   -100.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 0 $0   -100.00% 0.00%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2026 0 $0   -100.00% 0.00%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2026 0 $0   -100.00% 0.00%
CALIGAN PARTNERS LP 05/15/2026 0 $0   -100.00% 0.00%
SKYVIEW INVESTMENT ADVISORS, LLC 05/15/2026 0 $0   -100.00% 0.00%
SUPERSTRING CAPITAL MANAGEMENT LP 05/14/2026 0 $0   -100.00% 0.00%

Spruce Biosciences Inc institutional Ownership - FAQ's

During the previous two years, 45 institutional investors and hedge funds held shares of Spruce Biosciences Inc. The most heavily invested institutionals were:

Ikarian Capital, LLC: 121,356

MILLENNIUM MANAGEMENT LLC: 111,888

CITADEL ADVISORS LLC: 69,999

ADAR1 Capital Management, LLC: 58,600

Alyeska Investment Group, L.P.: 51,671

WELLINGTON MANAGEMENT GROUP LLP: 48,796

96.50% of Spruce Biosciences Inc stock is owned by institutional investors.

Institutional investors have bought a total of 5.61 M shares in the last 24 months. This purchase volume represents approximately $348.38 M in transactions.